日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

剪接因子 RBM10 的缺乏限制了 EGFR 突变肺癌中 EGFR 抑制剂的反应

Shigeki Nanjo, Wei Wu, Niki Karachaliou, Collin M Blakely, Junji Suzuki, Yu-Ting Chou, Siraj M Ali, D Lucas Kerr, Victor R Olivas, Jonathan Shue, Julia Rotow, Manasi K Mayekar, Franziska Haderk, Nilanjana Chatterjee, Anatoly Urisman, Jia Chi Yeo, Anders J Skanderup, Aaron C Tan, Wai Leong Tam, Oscar

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Aurora 激酶 A 推动肺癌对第三代 EGFR 抑制剂的耐药性演变

Khyati N Shah, Roma Bhatt, Julia Rotow, Julia Rohrberg, Victor Olivas, Victoria E Wang, Golzar Hemmati, Maria M Martins, Ashley Maynard, Jonathan Kuhn, Jacqueline Galeas, Hayley J Donnella, Swati Kaushik, Angel Ku, Sophie Dumont, Gregor Krings, Henry J Haringsma, Liliane Robillard, Andrew D Simmons,

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

晚期 EGFR 突变肺癌中同时发生的基因变异的演变和临床影响

Collin M Blakely, Thomas B K Watkins, Wei Wu, Beatrice Gini, Jacob J Chabon, Caroline E McCoach, Nicholas McGranahan, Gareth A Wilson, Nicolai J Birkbak, Victor R Olivas, Julia Rotow, Ashley Maynard, Victoria Wang, Matthew A Gubens, Kimberly C Banks, Richard B Lanman, Aleah F Caulin, John St John, A